-
A hundred years of retrospect of the light of medicine-tribute to the 100th anniversary of the discovery of insulin 2021...
Time of Update: 2021-06-23
, a media exchange meeting for the 100th anniversary of the discovery of insulin and 2021 "Healthy China E Get Up" Diabetes Popular science activities started to be held in Beijing .
-
Patients with type 2 diabetes can benefit from two JAMAs calling for more extensive continuous blood glucose monitoring...
Time of Update: 2021-06-23
-monitoring is a standard part of diabetes self-management, a considerable number of patients do not self-adjust insulin well .
>
Recently, the Journal of the American Medical
-
Hutchison Whampoa Sofantinib's new indication will be approved soon
Time of Update: 2021-06-23
On December 30 last year, Sofantinib was just approved for marketing for late-stage well-differentiated neuroendocrine tumors of non-pancreatic origin .
-
【Cell Reports】Heavy!
Time of Update: 2021-06-22
Recently, researchers from Northwestern University in the United States published a paper entitled "The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding" in Cell Reports .
-
New ideas, new drugs, new recommendations, writing experts will take you to "Consensus"
Time of Update: 2021-06-22
First of all, Professor Ma pointed out that for patients with T2DM combined with CVD, the "Consensus" introduced to cardiologists a new type of hypoglycemic drugs that can effectively reduce blood sugar and improve prognosis, including glucagon-like drugs.
-
Can diabetics also realize "freedom to eat"?
Time of Update: 2021-06-22
/> and Rizkalla, SW 2002. Four -week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism-Clinical and Experimental. 51(7), pp. 819-826. [2] Krawęcka, A. , Sobota
-
Countdown to 2021 ADA Annual Meeting!
Time of Update: 2021-06-22
02 Hypoglycemic drug treatment plan For the drug treatment of type 2 diabetes (T2DM), the new version of the ADA guidelines follow the previous standards, and once again emphasize the patient-centered guidance on the choice of drugs .
-
Pharmaceutical financing ViaCyte raised US$45 million to promote stem cell-derived therapies for type 1 diabetes
Time of Update: 2021-06-22
ViaCyte's stem cell-derived therapy product portfolio is the world's leading international original (first-in-category, first-in-class) product, which represents a major progress in the search for functional treatments for type 1 diabetes and other chronic diseases in the future .
-
A powerful scientific hypoglycemic picture gives you the answer!
Time of Update: 2021-06-22
*Only for medical professionals to read for reference.
-
1. Type 2 diabetes has ushered in new progress: support for approval, guideline recommendation, introduction authorization...
Time of Update: 2021-06-22
> 2. International clinical practice guidelines are released: Recommend SGLT-2 inhibitors or GLP-1 receptor agonists for adult type 2 diabetes patients with type 2 diabetes (T2D) as the most common metabolic disease, in the past 50 years
-
Type 1 and 2 diabetes have ushered in new progress: support for approval, introduction of authorization...
Time of Update: 2021-06-22
2. International clinical practice guidelines are released: SGLT-2 inhibitors or GLP-1 receptor agonists are recommended for adult patients with type 2 diabetes
-
The joint team of Nat Commun Liang Chongheng/Ma Dilong/Lin Ligen discovered a new hypoxia-inducible factor 1α stabilizer, which is expected to become a drug for the treatment of diabetic foot
Time of Update: 2021-06-22
>. At the same time, Dr. Carmelo Di Primo from the University of Bordeaux, France, Associate Professor Huang Jinwei from the State Key Laboratory of Chinese Medicine Quality Research (Macau
-
Review of the 2021 ADA Guidelines: "Glucose-lowering Drug Specificity and Patient Factors" Overview Knowledge Card
Time of Update: 2021-06-22
This article selects the relevant content of "Drug specificity and patient factors in the selection of hypoglycemic drugs for type 2 diabetes" in the 2021 ADA guidelines to share with you .
-
Controlling sugar and protecting the heart, composing a healthy movement, my country's first "Expert Consensus on Diagnosis and Treatment of Diabetes and Cardiovascular Diseases" was released in Beijing!
Time of Update: 2021-06-22
Diabetes and heart disease are the most common chronic diseases. If they are not treated in time
-
International guide is released!
Time of Update: 2021-06-22
differentiated recommendations for SGLT-2i and GLP-1RA? ➤Question 2: When prescribing SGLT-2i and GLP-1RA, do I need to consider HbA1c and blood sugar levels? ➤Question 3: What are the adverse reactions related to SGLT-2i and GLP
-
How does insulin titration work?
Time of Update: 2021-06-22
*Only for medical professionals to read for reference.
Basic insulin therapy is one of the important methods for clinical treatment of diabetic patients .
-
Lipid-lowering drugs enter the treatment of "hyperthyroidism"?
Time of Update: 2021-06-22
Introduction: Observational studies have found that statin users are significantly less likely to develop Graves' ophthalmopathy, and this benefit is especially obvious among men .
-
Exploring "Secretion" Hormone Replacement Therapy and Hormone Resistance-2021 Frontier Progress in Endocrine and Metabolic Diseases Summit Forum held in Tianjin
Time of Update: 2021-06-22
Professor Zhong Liyong from Beijing Tiantan Hospital, Capital Medical University, shared the clinical features and diagnosis and treatment experience of two special types of rare functional pituitary adenomas, namely functional gonadotropin (FGnA) tumors and thyroid-stimulating hormone (TSH) tumors .
-
Anti-diabetic martial arts, how does saxagliptin work together?
Time of Update: 2021-06-22
>. In mild renal insufficiency, that is, when creatinine clearance (CrCI) ≥50 ml/min (corresponding serum creatinine level ≤1. 7 mg/dl for men and ≤1. 5 mg/dl for women), saxagliptin
-
8 Tuo of poo that has passed through a thousand years, let Harvard scientists find clues to cure diabetes Nature
Time of Update: 2021-06-22
Recently, "Nature" published a paper on ancient human feces, which provided new clues for the study of type 1 diabetes, obesity and other diseases .
